Drug intelligence / Profile preview

azithromycin + fluconazole + secnidazole

Development stage
Unknown
Lead developer
Laboratory & Allied
Modality
Small Molecules
Administration
Oral
01

Overview

Gynagone (also marketed as Gynagone Kit) is a co-packaged syndromic management kit developed and manufactured by Laboratory & Allied. It is approved in East African countries, including Kenya, Rwanda, Tanzania, and Ethiopia, for the treatment of gynecological and vaginal infections (such as bacterial vaginosis, trichomoniasis, candidiasis, and mixed infections). The kit contains three active pharmaceutical ingredients: azithromycin (a macrolide antibiotic that inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit), fluconazole (a triazole antifungal that inhibits fungal lanosterol 14-alpha-demethylase), and secnidazole (a nitroimidazole antimicrobial that undergoes intracellular reduction to form reactive intermediates that damage microbial DNA).

Brand names
GynagoneGynagone Kit
Other names
azithromycin / fluconazole / secnidazoleazithromycin, fluconazole, and secnidazole
02

Targets

Bacterial 50S ribosomal subunitCYP51A1 (Sterol 14α-demethylase)NeuraminidaseDNA

Beyond the preview

Go deeper on azithromycin + fluconazole + secnidazole.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on azithromycin + fluconazole + secnidazole.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call